Fencamfamin

Fencamfamin
Clinical data
Pregnancy; category	?;
Routes of; administration	Oral
ATC code	N06BA06 (WHO) ;
Legal status
Legal status	BR: Class B1 (Psychoactive drugs); CA: Schedule IV; DE: Anlage II (Authorized trade only, not prescriptible); US: Schedule IV;
Pharmacokinetic data
Elimination half-life	16 hours
Identifiers
	IUPAC name N-Ethyl-3-phenyl-norbornan-2-amine;
CAS Number	1209-98-9 ;
PubChem CID	14584;
DrugBank	DB01463 ;
ChemSpider	13922 ;
UNII	NME1I5IGBK;
KEGG	D07343 ;
ChEMBL	ChEMBL7010 ;
Chemical and physical data
Formula	C15H21N
Molar mass	215.340 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCNC1C(C2CCC1C2)C3=CC=CC=C3;
	InChI InChI=1S/C15H21N/c1-2-16-15-13-9-8-12(10-13)14(15)11-6-4-3-5-7-11/h3-7,12-16H,2,8-10H2,1H3 ; Key:IKFBPFGUINLYQI-UHFFFAOYSA-N ;
	(what is this?) (verify)

Fencamfamin (INN), also known as fencamfamine or by the brand names Glucoenergan and Reactivan, is a stimulant which was developed by Merck in the 1960s.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.